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Background: How can HCV require only 10 proteins for decades-long evasion of the immune system?
Results: Phosphorylation of the intrinsically disordered domain (IDD) of NS5A changes its dynamics, inducing unique structure
and function.
Conclusion: IDD phosphorylation expands the HCV proteome.
Significance: Post-translational modification of a viral IDD represents a strategy to expand a viral proteome when coding
capacity is limited.
The human proteome contains myriad intrinsically disor-
dered proteins. Within intrinsically disordered proteins, poly-
proline-II motifs are often located near sites of phosphorylation.
We have used an unconventional experimental paradigm to dis-
cover that phosphorylation by protein kinase A (PKA) occurs in
the intrinsically disordered domain of hepatitis C virus non-
structural protein 5A (NS5A) on Thr-2332 near one of its poly-
proline-II motifs. Phosphorylation shifts the conformational
ensemble of the NS5A intrinsically disordered domain to a state
that permits detection of the polyproline motif by using 15N-,
13C-based multidimensional NMR spectroscopy. PKA-depen-
dent proline resonances were lost in the presence of the Src
homology 3 domain of c-Src, consistent with formation of a
complex. Changing Thr-2332 to alanine in hepatitis C virus gen-
otype 1b reduced the steady-state level of RNA by 10-fold; this
change was lethal for genotype 2a. The lethal phenotype could
be rescued by changing Thr-2332 to glutamic acid, a phospho-
mimetic substitution. Immunofluorescence and transmission
electron microscopy showed that the inability to produce
Thr(P)-2332-NS5A caused loss of integrity of the virus-induced
membranous web/replication organelle. An even more extreme
phenotype was observed in the presence of small molecule
inhibitors of PKA. We conclude that the PKA-phosphorylated
form of NS5A exhibits unique structure and function relative to
the unphosphorylated protein. We suggest that post-transla-
tional modification of viral proteins containing intrinsic disor-
der may be a general mechanism to expand the viral proteome
without a corresponding expansion of the genome.
Hepatitis C virus (HCV)2 establishes chronic infections in
humans that can persist for decades before causing any clinical
manifestations. The ability of a positive-strand RNA virus with
such limited coding capacity to so effectively evade host
defenses is extraordinary. A unique feature of HCV, relative to
most acute RNA viruses of similar genetic size and encoded
functions, is nonstructural protein 5A (NS5A). NS5A is a two-
domain protein. The amino-terminal domain can form at least
two structurally distinct homodimers (1, 2). One of these
dimers binds to RNA, with a preference for GU-rich RNA (3, 4).
The carboxyl-terminal domain is an intrinsically disordered
domain (IDD) (5, 6) that contains numerous putative sites of
phosphorylation and has been reported to bind dozens of cel-
lular proteins (7). The ability of NS5A to antagonize and/or to
hijack numerous cellular pathways may be a key determinant of
HCV persistence.
Specific combinations of post-translational modifications,
including phosphorylation, in the IDD of p53 confer the ability
to interface with myriad cellular pathways (8). Conformational
sampling of an IDD leads to multiple, unique structures capable
of unique interactions (8). Although empirical examples are
quite limited, the thought is that the addition of a post-transla-
tional modification to a specific location will restrict conforma-
tions sampled, thus channeling the IDD toward a single struc-
ture or subset of structures. Therefore, the interaction of NS5A
with so many proteins may rely on a similar mechanism, phos-
phorylation-dependent acquisition of structure.
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Several observations suggest an important role for NS5A
phosphorylation in HCV multiplication and/or pathogenesis.
First, persistent replication of the prototypical genotype 1b sub-
genomic replicon RNA in Huh-7 cells and sublines thereof
requires an adaptive mutation that changes Ser-2204 of NS5A
to Ile (9). The S2204I substitution prevents formation of the
hyperphosphorylated/p58 form of NS5A (9). It is becoming
increasingly clear that full-length genomes encoding adaptive
mutations fail to cause disease in chimpanzees (10, 11), consis-
tent with NS5A phosphorylation contributing to pathogenesis.
Inhibitors of host cell kinases have been shown to impact HCV
replication, presumably due to inhibition of NS5A phosphory-
lation (12, 13). In addition, the most potent direct acting anti-
HCV drug reported to date, daclatasvir, targets NS5A and alters
the phosphorylation state of the protein (14, 15). Finally, a clear
connection has been made between casein kinase II phosphor-
ylation in the carboxyl-terminal region of the IDD and viral
assembly (16, 17), although a molecular explanation for the gain
of function caused by phosphorylation remains a mystery.
Therefore, knowledge of the kinases responsible for NS5A
phosphorylation and the corresponding sites of phosphoryla-
tion (the NS5A phosphoproteome) is essential to understand
the role of individual phosphorylation states during the HCV
life cycle and to test the hypothesis that inhibitors of NS5A may
function by perturbing one or more phosphorylated states of
NS5A.
The inability to directly reveal the NS5A phosphoproteome
(e.g. by using mass spectrometry to analyze NS5A isolated from
HCV-infected hepatocytes) demands an alternative experi-
mental approach. Here we define a new experimental paradigm
to study phosphorylation of NS5A. We show that protein
kinase A (PKA) phosphorylation occurs near the poly-pro-
line-II (PPII) motif of NS5A, leading to changes in the confor-
mational sampling of this SH3 binding determinant. This phos-
phorylation-dependent change in NS5A dynamics is important
for replication because it contributes to the integrity of the rep-
lication organelle. We suggest that phosphorylation and other
post-translational modifications of viral IDPs represent an
important strategy for expanding the functional proteome of
viruses with limited coding capacity.
EXPERIMENTAL PROCEDURES
Construction of Recombinant NS5A Plasmids—NS5A 2005–
2419 was generated as described previously (18). Oligonucleo-
tides 1 and 2 (Table 1) were used with pET26-Ub-32-NS5A-
C(His) (encoding residues 2005–2419 of the polyprotein) to
amplify residues 2194 –2419. The NS5A deletion mutant 2005–
2306 was created using oligonucleotides 3 and 4 (Table 1).
NS5A containing P3, T2332A, or T2332E was amplified using
oligonucleotides 2 and 3 (Table 1) on pHCVbart.rep1/Ava-II-
P3 (3), pHCVbart.rep1/Ava-II-T2332A, or pHCVbart.rep1/
Ava-II-T2332E. The PCR fragments were digested and ligated
into pET26Ub-CHIS vector. All plasmid constructs were veri-
fied by restriction enzyme digestion and DNA sequencing.
Construction of NS5A Subgenomic Replicon Plasmids—
Oligonucleotides 5– 8 (Table 1) were used to perform overlap
extension PCR on pHCVbart.rep1/Ava-II to create the T2332A
derivative. The overlap PCR fragment was digested and ligated
into vector to generate pHCVbart.rep1/Ava-II-T2332A (T2332A).
The T2332E derivative, pHCVbart.rep1/Ava-II-T2332E, was
constructed with oligonucleotides 7–10 (Table 1) in the same
manner as the T2332A derivative. Both Thr-2332 derivatives
were also cloned in the context of the NS5A cell culture adaptive
mutation S2204I (SI), to generate SI/T2332A and SI/T2332E,
using pHCVbart.rep1/Ava-II-SI (3), as described above.
JC1 Reporter Plasmid Constructs—The plasmids pJC1/
GLuc2A and pJC1/GLuc2A(GNN) were described previously
(19). To construct the pJC1/GLuc2A(T2332A) and (T2332E)
replicons, a 3,676-bp fragment from pYSGR-JFH(T2332A) and
T2332E was subcloned into pJC1/GLuc2A using common SpeI
and BsrGI restriction sites, generating pJC1/GLuc2A(T2332A)
and (T2332E) replicons.
Expression and Purification of NS5A, NS3, and NS5B Pro-
teins—All NS5A, NS3, and NS5B proteins (genotype 1b) used in
this study were expressed and purified as described previously
(4, 18, 20, 21).
In Vitro Phosphorylation Assays—PKA- or CK2-mediated
phosphorylation of HCV non-structural proteins was per-
formed in 50 mM HEPES, pH 7.5, 0.5 mM tris(2-carboxyethyl)-
phosphine, 20 mM MgCl2, 100 mM NaCl, 125 M ATP, 0.5
Ci/l [-32P]ATP (MP Biomedicals), and 1 M NS3, NS5A,
NS5A derivative, or NS5B. For reactions that did not require
the use of radiolabeled ATP, the [-32P]ATP was omitted.
Reactions performed in the presence of PKA inhibitors or
NS5A inhibitor BMS-790052 were performed by incubating 5
nM PKA with inhibitor at 37 °C for 30 min, after which point
NS5A was added to 0.5 M, and phosphorylation proceeded for
the specified time. The phosphorylation reaction was quenched
with an equal volume of 2 SDS-PAGE sample buffer. The
samples were resolved by 8% SDS-PAGE. For reactions con-
taining radiolabeled ATP, the gels were analyzed with the
Typhoon phosphorimager (GE Healthcare) and quantified with
ImageQuant software. The amount of phosphorylation was
normalized to the amount of radioactivity present in each lane.
Gels of reactions not using radiolabeled ATP were analyzed by
Western blot. PKA-phosphorylated NS5A IDD used for NMR
was prepared as described above but with 100 M isotopically
labeled IDD, 250 M ATP, and 10 M PKA. Reactions pro-
ceeded for 60 min. Phosphorylation reactions were then
desalted using a Zeba column pre-equilibrated with NMR
buffer.
Mass Spectrometric Mapping of Phosphorylation Site—Anal-
ysis of the PKA-phosphorylated residues on NS5A was per-
formed by mass spectrometry with 8 g of NS5A phosphory-
lated by PKA. A sample of the quenched reaction was resolved
by 8% SDS-PAGE and stained with Pro-Q Diamond phospho-
protein gel stain (Invitrogen) to verify that NS5A had been
phosphorylated by PKA. The remaining reaction was resolved
by 8% SDS-PAGE, and the NS5A band was visualized by Coo-
massie staining. Peptides obtained from in-gel trypsin digestion
of the Coomassie-stained band corresponding to in vitro phos-
phorylated NS5A were analyzed by LC/MS/MS. Tandem MS
spectra obtained by collision-induced dissociation were
acquired using an LC/MS/MS system that consisted of a Sur-
veyor HPLC pump, a Surveyor Micro AS autosampler, and an
LTQ linear ion trap mass spectrometer (ThermoFinnigan). The
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acquired spectra were processed using Xcalibur version 2.0.
The raw tandem MS spectra were also converted to Mascot
generic files (.mgf). Detection and mapping of the phosphory-
lation site were achieved by database searching of tandem mass
spectra of the proteolytic peptides against a current Swiss-Prot
protein database using the Bioworks version 3.2 and Mascot
version 2.2 (Matrix Science) search engines. The database
searches were performed with cysteine carbamidomethylation
as a fixed modification. The variable modifications were methi-
onine oxidation (16 Da) and phosphorylation (80 Da) of
Ser, Thr, and Tyr residues. Up to two missed cleavages were
allowed for trypsin digestion. Peptide mass tolerance and frag-
ment mass tolerance were set to 3 and 2 Da, respectively. Tan-
dem MS spectra that are matched to phosphorylated peptides
were manually evaluated at the raw data level with the consid-
eration of overall data quality, signal/noise ratio of matched
peaks, and the presence of dominant peaks that did not match
to any theoretical m/z value.
NS5A Alignment—HCV sequence alignments were per-
formed using the Los Alamos HCV Sequence Database (22).
Genotype references of the NS5A protein sequence were com-
pared to determine the conservation of the PKA phosphoryla-
tion site, residue Thr-2332.
Calculation of IC50 Values of PKA Inhibitors—Phosphoryla-
tion of NS5A in the presence of specified PKA inhibitors was
performed in 50 mM HEPES, pH 7.5, 0.5 mM tris(2-carboxyeth-
yl)phosphine, 20 mM MgCl2, 100 mM NaCl, 50 M ATP, 0.5
Ci/l [-32P]ATP, and 0.005 M PKA. Reactions were incu-
bated with 0 –50 M PKA inhibitor H-7 dihydrochloride, H-89
dihydrochloride, KT-5720, or the myristoylated peptide frag-
ment 14 –22 (Sigma), each in a final DMSO concentration of
2.5% in the reaction, at 37 °C for 30 min. After 30 min, NS5A
was added to 0.5 M, and phosphorylation proceeded for 30
min. The phosphorylation reaction was quenched with 2
SDS-PAGE sample buffer. The samples were resolved by 8%
SDS-PAGE. Data were fit to a hyperbolic equation to calculate
the respective IC50 for each inhibitor.
Antibodies—Rabbit polyclonal anti-NS5A, anti-NS3, and
anti-NS5B were generated using purified protein immunogens
by Covance, Inc. for our use. Rabbit polyclonal phospho-spe-
cific anti-Thr(P)-2332-NS5A was generated using the synthetic
peptide PPRRKRpTVVLSESC conjugated to keyhole limpet
hemocyanin by Covance Research Products, Inc. for our use.
Mouse monoclonal anti-NS5A was purchased from Advanced
Immunochemical Services, Inc. Rabbit polyclonal anti-NS4B
was a gift from Dr. Kouacou Konan (Albany Medical College).
Rabbit polyclonal anti-giantin and mouse monoclonal anti--
actin were purchased from Abcam. Mouse monoclonal anti-
PKAc was purchased from BD Transduction Laboratories.
Goat monoclonal anti-calnexin was purchased from Origene.
Alexa Fluor 488 goat anti-mouse, Alexa Fluor 488 goat anti-
rabbit, Alexa Fluor 594 goat anti-rabbit, and Alexa Fluor 594
donkey anti-mouse IgG were purchased from Invitrogen. The
goat anti-rabbit HRP, goat anti-rabbit AP, goat anti-mouse AP,
bovine anti-goat HRP, and bovine anti-goat AP were purchased
from Santa Cruz Biotechnology, Inc.
Cell Culture—Huh-7.5 cells were maintained in DMEM, as
described previously (3). Stable cell lines were maintained in
supplemented DMEM containing 0.5 mg/ml G418. Where
specified, cells were treated with DMSO; PKA inhibitor H-7,
H-89, or KT-5720 or the myristoylated peptide fragment 14 –22
(all from Sigma); or NS5A inhibitor Daclatasvir (BMS-790052)
for the designated times prior to harvesting.
Transient Transfection of HCV RNA—In vitro transcribed
subgenomic RNA was transfected into Huh-7.5 cells using the
TransMessenger transfection system (Qiagen). Briefly, 1.6 
106 cells were mixed with 2 g of RNA per the manufacturer’s
protocol. For colony formation assays, 0.5  106 cells were
plated in 100-mm dishes. Cells were selected under DMEM
containing 0.5 mg/ml G418 for 3 weeks, exchanging G418-con-
taining media every 3 days.
Cell Culture and RNA Transfection for JC1/GLuc2A Replica-
tion and Infectivity Experiments—Huh-7.5 cells were main-
tained in DMEM supplemented with 10% fetal calf serum
(HyClone, Logan, UT) and 1 mM nonessential amino acids
(Invitrogen). Cells were seeded at 0.2  106 cells/ml/well in
12-well plates and transfected with HCV RNA transcripts by
using the TransIT-mRNA transfection kit (Mirus Bio, Madi-
son, WI).
Replication and Infectivity Measurements Using JC1/GLuc2A
Reporter Viruses—To measure the relative replication of JC1/
GLuc2A reporter viruses, cell culture medium was collected at
various time points post-transfection, clarified by centrifuga-
tion (16,000  g for 5 min), and mixed with 1⁄4 volume of Renilla
5 lysis buffer (Promega, Madison, WI) to kill infectious HCV.
GLuc activity was measured, as described previously (19), on a
Berthold Centro LB 960 luminescent plate reader with 20 l of
sample injected with 50 l of Gaussia luciferase assay reagent
(New England Biolabs), integrated over 10 s. To measure rela-
tive infectivity, cell culture media containing infectious virus
were collected at various times post-transfection, clarified by
centrifugation, and stored at 80 °C. The virus supernatants
were used to infect naive Huh-7.5 cells seeded at 0.2  106
cells/ml/well in 12-well plates. After 6 h of virus adsorption,
cells were washed three times with Dulbecco’s PBS and incu-
bated with complete medium for an additional 72 h. Cell cul-
ture media were collected, clarified, and assayed for GLuc activ-
ity as described above.
RT-qPCR—Total RNA was extracted from subgenomic rep-
licon transfected Huh-7.5 cells using the RNeasy Plus RNA
extraction system (Qiagen). The RT-qPCR was performed at
the Nucleic Acid Facility at Penn State. Oligonucleotides 11 and
12 were used for reverse transcription. The Taqman primer
5-CGC CGC CAA GCT CTT CAG CAA-3 was used on an
Applied Biosystems 7300 system. In vitro transcribed RNA was
used to quantify the copy number in cells.
Western Blot Analysis—Recombinant proteins or cell extracts
from transiently transfected cells or stable cell lines were sepa-
rated on 8% SDS-polyacrylamide gels and transferred to nitro-
cellulose membrane. Membranes were probed with the appro-
priate antibodies. Proteins were detected by ECL (Millipore) or
ECF (GE Healthcare) Western blot detection reagents. ECF-
detected blots were visualized by TyphoonImager (GE Health-
care) and quantified using NS5A or PKA-phosphorylated
NS5A standards via ImageQuant software.
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Northern Blot Analysis—For Northern blotting, 0.5 and 2.0
g of total RNA from stable cell lines was separated on a 0.6%
agarose gel of 0.8 M formaldehyde in 20 mM MOPS buffer con-
taining 5 mM sodium acetate and 1 mM EDTA and transferred
to a nylon membrane in 150 mM sodium chloride, 15 mM
sodium citrate, pH 7.0. Additionally, 0.5, 1.0, 5.0, and 10.0 ng of
in vitro transcribed subgenomic replicon RNA was used as a
positive control. The RNA was UV-cross-linked to the mem-
brane and incubated with radiolabeled probes for 12 h. The
probes were generated by PCR using oligonucleotides 13 and
14 (Table 1) with pHCVbart.rep1/Ava-II and labeled with
[-32P]dATP (MP Biomedicals). RNA was visualized by the
Typhoon imager (GE Healthcare) and quantified using
ImageQuant software.
Cycloheximide (CHX) Treatment—Huh-7.5 cells stably rep-
licating the SI, SI/T2332A, and SI/T2332E subgenomic repli-
cons were incubated in the presence of 100 g/ml CHX for 48 h
and harvested every 12 h for analysis via Northern and Western
blotting and immunofluorescence.
Immunofluorescence—Cells were seeded on coverslips in
6-well plates. After the designated time and any specified treat-
ment, the cells were washed with PBS and fixed for 15 min in 4%
formaldehyde in PBS. Cells were washed with PBS, permeabi-
lized for 5 min in 0.05% Triton X-100 in PBS, and washed with
PBS. The cells were blocked with 3% BSA in PBS for 15 min and
double-stained by incubation for 1 h each with primary anti-
body A followed by primary antibody B. Cells were incubated
for 1 h each with Alexa-488- or Alexa-594-conjugated second-
ary antibodies (Invitrogen). After each antibody incubation,
PBS was used to wash cells. The coverslips were mounted on
glass slides in Vectashield with DAPI (Vectashield Laborato-
ries, Inc., Burlingame, CA) and sealed with nail polish. Samples
were analyzed by fluorescence microscopy (Zeiss Axiovert 200
M) with a 63 lens, and digital images were taken with an
Axiocam MRm CCD camera. Optical sections were decon-
volved using Axiovision software.
Confocal Microscopy—Slides prepared for immunofluores-
cence were also used for confocal microscopy. Confocal analy-
sis was performed on an Olympus Fluoview 1000 microscope
with an Olympus IX70 inverted microscope with fluorescence
burner and four single-line lasers with individual shutters that
are software-controlled for sequential acquisition: violet (405
nm, 10 milliwatts), blue argon (488 nm, 10 milliwatts), green
HeNe (543 nm, 10 milliwatts), and red HeNe (633 nm, 10 mil-
liwatts). Images were taken using the PlanApo 60/1.4 oil
objective and the two-dimensional X-Y scanning mode. Data
were analyzed with the Olympus Fluoview version 3.0a soft-
ware. Quantification was performed using Pearson’s coefficient
of colocalization between the green (NS5A) and red (NS4B)
channels, and the statistical significance was calculated using a
two-tailed paired Student’s t test. Colocalization of NS5A and
NS4B was calculated using 20 cells per cell line from three inde-
pendent experiments.
Electron Microscopy—For ultrastructural analysis, cells were
trypsinized, resuspended in complete DMEM, and processed as
follows. Single cell suspensions were transferred to microcen-
trifuge tubes and pelleted at 1,000  g for 10 min. The cell
pellets were fixed with an ice-cold fixative containing 2% glutar-
aldehyde in 0.1 M phosphate buffer, pH 7.4, at room tempera-
ture for 1 h and then postfixed in 1% OsO4 for 1 h. Samples were
dehydrated with a serial treatment in graded ethanol and
embedded in Eponite 12. Areas of interest were selected under
a dissecting microscope, and 80-nm-thick sections were pro-
duced with a Leica UC6 ultramicrotome. Sections were con-
trasted with uranyl acetate/lead citrate and examined with an
FEI Tecnai Spirit transmission electron microscope (FEI, Hills-
borough, OR) at 120 kV.
Expression and Purification of 15N-, 13C-Labeled NS5A
IDD—NS5A IDD was expressed from the pSUMO-N(His)-
NS5A IDD C2215S/C2314S plasmid (encoding residues 2212–
2417 of the polyprotein). Rosetta(DE3) cells containing the
expression plasmid were grown in NZCYM supplemented with
25 g/ml kanamycin (K25) and 20 g/ml chloramphenicol
(C20) at 37 °C to A600  0.8. The culture was used to inoculate
4 liters of NZCYM with K25 and C20 to A600  0.025. The
cultures were grown at 37 °C to A600  0.8 and then harvested
and washed with M9 media without ammonium or dextrose.
The cells were resuspended in 1 liter of M9 medium with
15NH4Cl, [13C]glucose, K25, and C20 and grown at 37 °C to
A600  5. The cultures were then cooled to 20 °C, and 0.8 mM
isopropyl 1-thio--D-galactopyranoside was added. The cul-
tures were then grown at 20 °C for 12–15 h and then harvested.
The cells were lysed in 100 mM potassium phosphate, pH 8,
buffer with 500 mM NaCl, 10 mM -mercaptoethanol, 10% glyc-
erol, and 20 mM imidazole supplemented with protease inhibi-
tors pepstatin A (10.0 g/ml), leupeptin (10.0 g/ml), and one
protease inhibitor mixture tablet per 4 g of cell paste (Roche
Applied Science, catalog no. 1-873-580) by passing through a
TABLE 1
Oligonucleotides used in this study
Number Name Sequence
1 HCV-NS5A-2194-NcoI-for 5-CGC GCC ATG GAT CCT CTG GTT CTC CCC CCT CCT TGG CC-3
2 HCV-NS5A-HindIII-rev 5-GGT ACC AAG CTT CTA TTA GCA GCA GAC GAC GTC CTC ACT-3
3 HCV-32-NS5A-NcoI- for 5-GCG GGT ACC CCA TGG ATC CTC TGG TGG AGT CCC CTT CTT-3
4 HCV-NS5A- 2307-HindIII-rev 5-GGC AAG CTT CTA TTA GTA GTC CGG GTC CTT CCA-3
5 HCV-NS5A-T2332A-for 5-CCA CGG AGG AAG AGG GCG GTT GTC CTG TCA GAA-3
6 HCV-NS5A-T2332A-rev 5-TTC TGA CAG GAC AAC CGC CCT CTT CCT CCG TGG-3
7 HCV-NS5A-XhoI-for 5-GCG AAA TTC CCT CGA GCG ATG CCC ATA-3
8 HCV-NS5B-MfeI-rev 5-GCG GGT GGT GTC AAT TGG TGT CTC-3
9 HCV-NS5A-T2332E-for 5-CCA CGG AGG AAG AGG GAG GTT GTC CTG TCA GAA-3
10 HCV-NS5A-T2332E-rev 5-TTC TGA CAG GAC AAC CTC CCT CTT CCT CCG TGG-3
11 HCV-rep-RT-PCR-for 5-GGA AGC GGT CAG CCC AT-3
12 HCV-rep-RT-PCR-rev 5-GCG TTG GCT ACC CGT GAT-3
13 HCV-Northern-for 5-GGG TGC TTG CGA GTG CC-3
14 HCV-Northern-rev 5-GGC CAG TAA CGT TAG GGG-3
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French Press (SIM-AMINCO) twice at 16,000 p.s.i. Immedi-
ately after lysis, PMSF was added to a final concentration of 1
mM, and Nonidet P-40 was added to 0.5%. The extract was
clarified by ultracentrifugation for 30 min at 25,000 rpm
(75,000  g) at 4 °C. The clarified lysate was loaded onto a
Ni-NTA-agarose column. The column was washed with 5 col-
umn volumes of 5 and 50 mM imidazole. The protein was eluted
with buffer containing 500 mM imidazole, and Ulp1 protease
was used to cleave the SUMO tag. The cleaved NS5A IDD pro-
tein was purified from the SUMO by running the sample over
another Ni-NTA-agarose column. The sample was then passed
over a Q-Sepharose, pH 6, column and an S-200 column. The
purified protein was dialyzed into NMR analysis buffer (50 mM
HEPES, pH 7.5, 100 mM NaCl, 10 mM -mercaptoethanol, 10%
glycerol) and brought to a final concentration of 400 M, and
10% (v/v) D2O was added right before analysis.
Expression and Purification of His-c-Src-SH3—His-c-Src-
SH3 was expressed from the pET-Ub-based plasmids that
are fused to yeast ubiquitin at the amino terminus (23).
BL21(DE3)pCG1 cells containing the expression plasmid were
grown in 100 ml of NZCYM with K25 and C20 at 37 °C to
A600  1.0. The culture was used to inoculate 1 liter of autoin-
ducing medium (24) with K25, C20 to A600  0.025. The cells
were grown at 37 °C to A600  0.8 and then cooled to 20 °C,
grown overnight (12–14 h), and then harvested. Cells were
lysed by passing through a French Press. PMSF was added to a
final concentration of 1 mM, and Nonidet P-40 was added to
0.5%. The extract was clarified by ultracentrifugation for 30 min
at 25,000 rpm (75,000  g) at 4 °C. The supernatant was loaded
onto a Ni-NTA-agarose column and purified using the stan-
dard manufacturer’s protocol. Protein was eluted with 500 mM
imidazole and dialyzed into the NMR analysis buffer and
brought to a final concentration of 1 mM and 10% (v/v) D2O.
NMR Spectroscopy—All spectra were acquired on uniformly
15N and 13C isotope-enriched samples at a concentration rang-
ing from 0.4 to 0.7 mM in 50 mM HEPES buffer (pH 7.5), 100 mM
NaCl, 10 mM -mercaptoethanol, 5% glycerol, and 10% D2O.
All of the NMR experiments were recorded at 11.7 T on a
Bruker AVANCE-3 spectrometer operating at a 1H frequency
of 500.13 MHz and equipped with a TCI cryoprobe. All spectra
were collected at 298 K. Typical pulse times were 9.79 and 31 s
for hard 1H and 15N 90 pulses, respectively, with some sample-
based variation in the 1H pulse time. All pulsed field gradients
used in the experiments were applied for 1 ms with a sine shape.
In all pulse sequences, unless otherwise noted by Sahu et al.
(25), the 90 band-selective 13C pulses have the Q5 shape (or
time reversed, Q5tr), and the band-selective 13C 180 pulses use
the Q3 shape with durations of 384 and 307 s, respectively.
The standard 1H,15N HSQC, C_CON, HNCO, and HNCACO
experiments were used from the TopSpin pulse program
library. Chemical shift assignments of residues found in the
proline region of the 15N,13C CON were generated as described
by Sahu et al. (25). Briefly, several of the proline resonances
were uniquely assigned by their presence in the Ala-specific
CON, Ser-specific CON, and TAVI-specific CON spectra.
Additional resonance assignments were generated from (HN-
flip)N(CA)CON and (HN-flip)N(CA)NCO spectra (25). All
NMR data were processed in TopSpin version 2.1 and con-
verted to Sparky (26) format for data analysis. For the c-Src SH3
titrations (0 –2 molar eq), purified c-Src SH3 was added to the
same sample of 15N-, 13C-labeled NS5A IDD from a 1 mM stock,
and the sample was concentrated back to its original volume,
and spectra were collected. All 15N,13C CON spectra for the
c-Src SH3 titrations were collected with 16 scans of signal aver-
aging and 256 increments in the indirect dimension, yielding a
total measurement time of 2 h/spectrum. Final data matrix
dimensions were 512  2,048 points, with sweep widths of
36.00 and 20.00 ppm in the 15N and 13C dimensions,
respectively.
RESULTS
Phosphorylation of NS5A on Thr-2332 by PKA in Vitro—
HCV NS5A is a phosphoprotein (27). Examples of a link
between a specific kinase, a specific site of phosphorylation on
NS5A, and a biological function/activity of NS5A remain the
exception rather than the rule. This circumstance is further
complicated by the fact that mass spectrometry of NS5A iso-
lated from cells replicating HCV RNA has not yielded substan-
tial biological insight (28 –32). Therefore, a new paradigm for
studying NS5A phosphorylation and the function thereof is
needed. We reasoned that as long as a protein is folded, specific
phosphorylation might be observed in vitro, especially if our
criteria also demanded a stoichiometry of phosphorylation that
was greater than or equal to 1. We chose to study PKA because
prior biochemical evidence suggested that NS5A is a substrate
for this kinase (33). The NetPhosK server predicted one site of
PKA phosphorylation at NS5A position Thr-360, correspond-
ing to Thr-2332 of the HCV polyprotein. PKA was also a good
test case because the NetPhosK server predicted six sites of
phosphorylation in NS3 and three in NS5B. However, for the
predicted phosphorylation sites in NS3 and NS5B to be acces-
sible to the kinase active site, tertiary contacts would need to be
lost, and, in some cases, secondary structure would need to be
lost as well (Fig. 1A).
We observed stoichiometric phosphorylation of NS5A (Fig.
2A) but less than 0.1 eq of phosphate incorporated into NS3 or
NS5B under the same conditions (Fig. 1B). That Thr-2332 was
the site of phosphorylation was supported by biochemical anal-
ysis of NS5A deletion constructs (Fig. 1C), mass spectrometry
(Fig. 2B), and site-directed mutagenesis (Fig. 2C). Thr-2332 is
located within a sequence that has been shown to function as a
nuclear localization signal, although the biological relevance of
the nuclear localization signal remains to be determined (34).
Thr-2332 is also adjacent to one of the two PPII motifs known
to be important for interactions of NS5A with SH3 domains of
several cellular proteins (35, 36). Importantly, Thr-2332 is pres-
ent in all genotypes that have been shown to replicate in cell
culture and those that seem to be the most recalcitrant to the
current standard of care in the clinic (Table 2).
We used our knowledge of the PKA phosphorylation site on
NS5A to produce an antibody that specifically recognized the
PKA-phosphorylated form of NS5A (referred to as Thr(P)-
2332-NS5A throughout). This antibody recognized NS5A that
had been phosphorylated by PKA (lane 3 of panel pT2332-
NS5A in Fig. 2D) but not that which had been phosphorylated
by casein kinase 2, CK2 (lane 4 of panel pT2332-NS5A in Fig.
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2D). That Thr-2332 is the site of PKA phosphorylation was
further supported by the inability of the antibody to recognize
the T2332A derivative of NS5A that had been treated with PKA
(lane 6 of panel pT2332-NS5A in Fig. 2D). The presence of a
negative charge at position 2332 (T2332E derivative of NS5A)
was not recognized by the antibody, consistent with the phos-
phate moiety contributing to the epitope recognized by the
antibody (lane 8 of panel pT2332-NS5A in Fig. 2D).
Phosphorylation of NS5A on Thr-2332 in Cells Replicating
HCV RNA—It is now well established that sublines of the
human hepatoma 7 cell line, in our case Huh-7.5 (37), can be
used to efficiently establish a cell culture in which HCV RNA of
genotype 1b (consensus 1 sequence) can be replicated persis-
tently as long as an adaptive mutation(s) is present (9). Here we
use a subgenomic replicon encoding the S2204I adaptive sub-
stitution in NS5A (denoted SI throughout). The replicons also
contain coding sequence for neomycin phosphotransferase,
thus permitting cells replicating HCV RNA to be selected in the
presence of G418 (37).
We engineered the T2332A and T2332E substitutions into
the SI replicon. We were able to transduce G418 resistance to
Huh-7.5 cells as efficiently as observed for the SI replicon
encoding Thr-2332 (Fig. 3A). It is worth noting that substitu-
tions at position 2332 were not themselves adaptive (Fig. 3A)
and had no significant impact on production of the p58 form of
NS5A or the observed ratio of p58/p56 (Fig. 3B). Cell cultures
persistently replicating SI/T2332A or SI/T2332E replicons
expressed NS5A (lanes 5 and 6 of panel NS5A in Fig. 3C),
although the steady-state level of NS5A was reduced 3-fold (Fig.
3D). Use of the Thr(P)-2332-NS5A antibody clearly showed
reactivity in cells replicating the SI replicon (lane 4 of panel
pT2332 in Fig. 3C) that was absent when Thr-2332 was changed
FIGURE 1. PKA specifically phosphorylates NS5A in vitro. A, the conserved NetPhosK-predicted PKA phosphorylation sites on HCV NS3 and NS5B are
inaccessible to the kinase without the loss of secondary and/or tertiary structure. The five putative PKA phosphorylation sites on NS3 protease (left), the one site
on NS3 helicase (middle), and the three sites on NS5B polymerase (right) are shown in red on the crystal structure. Residue numbering corresponds to the HCV
sequence of the respective crystal structures. B, PKA does not phosphorylate HCV NS3 or NS5B in vitro. Left, purified recombinant HCV non-structural proteins,
with 1 g loaded per lane. Right top, stoichiometric phosphorylation of HCV non-structural proteins by PKA showed specificity of the kinase for NS5A. Right
bottom, quantification of the top panel with numbers corresponding to the amount of phosphate incorporated/mol of viral protein after 60 min. The numbers
in parentheses below the labels correspond to the number of predicted PKA-phosphorylated residues based on NetPhosK prediction with a 0.5 threshold
setting. C, PKA phosphorylates NS5A within residues 2307–2419. Top, schematic representation of NS5A constructs used to verify the site of PKA phosphory-
lation in NS5A. Full-length NS5A consists of amino acids 1973–2419 of the HCV polyprotein using Con1 numbering. NS5A contains three clusters of highly
conserved serine-rich regions, denoted P1 (residues 2194 –2210), P2 (residues 2246 –2269), and P3 (residues 2380 –2409). The amino-terminal 32-amino acid
amphipathic -helix was removed for purification purposes, yielding 32-NS5A (residues 2005–2419) (1). Truncations of this construct included 2194 –2419 (2),
2005–2306 (3), and P3 (4). Bottom, stoichiometric phosphorylation of NS5A truncations with PKA indicated that the target residue was located within
2307–2419, but not within P3, based on a lack of phosphate incorporation using NS5A truncation 2005–2306 (lane 3).
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to alanine or glutamic acid (lanes 5 and 6 of panel pT2332 in Fig.
3C, respectively). Therefore, Thr-2332 of NS5A is phosphory-
lated in cells replicating HCV RNA. When quantified, we found
that only 20% of total NS5A was phosphorylated on Thr-2332
(Fig. 3D). Huh-7.5 cells express a protein that reacted with the
Thr(P)-2332-NS5A antibody (lane 3 of panel pT2332-NS5A in
Fig. 3C), consistent with the existence of one protein in the
human proteome having the exact sequence as that found
in NS5A that was used as the antigen (accession number
Q9UBX2).
Given that only a subset of NS5A was phosphorylated on
Thr-2332, we used immunofluorescence microscopy to deter-
mine whether Thr(P)-2332-NS5A localized to a unique place in
the cell relative to other/major form(s) of NS5A. Evaluation of
Huh-7.5 cells showed that the Thr(P)-2332-NS5A antibody
stained the nucleus most intensely (panel mock in Fig. 3E). Eval-
uation of cells replicating the SI replicon showed colocalization
of Thr(P)-2332-NS5A with bulk NS5A (panel SI in Fig. 3E). As
expected, substitution of Thr-2332 with alanine or glutamic
acid failed to show any colocalization, thus confirming that the
observed colocalization was not between NS5A and the cellular
protein recognized by the Thr(P)-2332-NS5A antibody.
Thr(P)-2332-NS5A Influences Steady-state Levels of RNA for
Genotype 1b HCV but Is Essential for Replication and Infectious
Virus Production by Genotype 2a HCV—Because transduction
of G418 resistance to cells provides no information on the levels
of RNA produced in the cell, we were motivated to take a closer
look at replication in cells in which the Thr(P)-2332/Thr-2332
ratio was perturbed. By using both RT-qPCR (Fig. 4A) and
Northern blotting (Fig. 4B), it was clear that loss of the Thr(P)-
FIGURE 2. PKA phosphorylates NS5A on Thr-2332. A, kinetics of NS5A phosphorylation by PKA in vitro were monitored by using gel electrophoresis (top) to
identify phosphorylated NS5A (NS5A-P). Care was taken to retain labeled ATP on gel, thus permitting quantitation (bottom) of phosphorylated NS5A, indicating
that 1 eq of phosphate was incorporated/molecule of NS5A. B, spectrum of the shown peptide obtained by tandem mass spectrometry indicating phosphor-
ylation on Thr-2332. C, NS5A derivatives having Thr-2332 changed to alanine (T2332A) or glutamic acid (T2232E) were treated with labeled ATP and PKA for 60
min and analyzed as in A. Loss of Thr-2332 prevented phosphorylation, consistent with this residue being the site of phosphorylation. D, an antibody was
produced that specifically recognizes Thr(P)-2332-NS5A. Experimental validation of the specificity is shown, using NS5A wild type and the indicated deriva-
tives. Phosphorylation was performed in vitro with PKA or CK2, resolved by gel electrophoresis, and then processed for Western blotting. Top, anti-Thr(P)-2332-
NS5A was used; bottom, anti-NS5A was used.
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2332/Thr-2332 ratio resulted in a nearly 10-fold reduction in
the steady-state level of RNA. Interestingly, the impact of the
perturbed Thr(P)-2332/Thr-2332 ratio was manifested only
after multiple passages as if partitioning of replicated RNA dur-
ing cell division was impacted (Fig. 4C). The lower steady-state
level of RNA correlated directly with a lower steady-state level
of the non-structural proteins (Fig. 4D) without a change in the
stability of these proteins (Figs. 5, A and B) or the replicon RNA
(Fig. 5, C and D). Collectively, these data reveal a unique func-
tion for a phosphorylated species of NS5A in maintenance of
HCV RNA at maximal levels in cells persistently replicating
genotype 1b HCV RNA.
Because of the known role of some NS5A phosphorylation
events in infectious virus production, we turned to a model that
would permit the role of Thr-2332 phosphorylation on virus
assembly to be determined. For this, we used the Jc1/GLuc2A
reporter virus, which is a genotype 2a HCV strain that expresses
a secretable Gaussia luciferase (19). This reporter virus effi-
ciently replicates and secretes luciferase in proportion to virus
replication, facilitating rapid measurements of viral replication
and infectivity. Furthermore, JC1/GLuc2A infectious virus pro-
duction can be monitored by measuring the amount of secreted
luciferase activity produced by reporter virus in infected cells,
and the level of luciferase produced is relative to the amount of
input virus (19).
In contrast to our observations with genotype 1b, the geno-
type 2a replicon encoding the T2332A NS5A variant was inca-
pable of replicating (T2332A in Fig. 4E). In fact, this change was
as debilitating as a genome encoding an inactive polymerase
(GNN in Fig. 4E). Unexpectedly, the T2332E NS5A variant rep-
licated as well as wild type (T2332E in Fig. 4E). The same phe-
notypes were observed when infectious virus was monitored
(Fig. 4F). Together, these results would suggest that Thr(P)-
2332 is essential for replication of genotype 2A HCV and that
T2332E phenocopies Thr(P)-2332 in this context.
Thr(P)-2332 Shifts the Conformational Ensemble of the SH3-
binding PPII Motif in the IDD of NS5A—As shown in Fig. 6A,
the NS5A IDD contains two PPII motifs, which have been
termed PPII.1 and PPII.2 (35, 38). Thr(P)-2332 is located adja-
cent to these motifs (Fig. 6A). Reverse-genetic, biochemical,
and biophysical studies have implicated this region of NS5A in
binding to a variety of cellular SH3 domains (35, 36, 38, 39).
However, no study has monitored the PPII motifs directly. We
reasoned that if we could accomplish this goal, then we would
be able to determine whether and how Thr(P)-2332 impacts the
PPII motifs and how these motifs interact with an SH3 domain.
The recent realization that many of the phosphorylation sites in
cellular IDPs are located adjacent to a PPII motif expanded the
relevance of studying the relationship between PPII motifs and
phosphorylation (40).
The absence of an amide proton for prolines located in a
polypeptide chain precludes the use of an NMR strategy built
around 1H,15N HSQC experiments for direct visualization of
these prolines. We therefore built our NMR strategy around the
15N,13C CON experiment, using recently developed multidi-
mensional NMR techniques for the analysis and chemical shift
assignments of IDPs that do contain resonances corresponding
to proline residues (25). We expressed and purified isotopically
15N-, 13C-labeled NS5A IDD and acquired double and triple
resonance spectra on both the unphosphorylated and PKA-
phosphorylated proteins. The 15N,13C CON spectrum of
unphosphorylated HCV NS5A IDD shows nice chemical shift
dispersion, with well resolved resonances in the proline region
of the spectrum (Fig. 6B). Although NS5A IDD has 25 prolines,
far fewer proline resonances were observed in the spectrum.
The absence of resonances for many of the prolines is probably
due to conformational exchange of the proline-rich region
TABLE 2
Conservation of PKA phosphorylation site in NS5A across HCV
genotypes
Shown is an alignment of HCV genotypes using the Los Alamos HCV Sequence
Database, with the PKA phosphorylation site shown in boldface type. The numbers
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within the IDD between multiple conformations on the milli-
second time scale. Additional evidence supporting this conclu-
sion is provided by the diverse line widths (and resulting signal
intensities) of the proline resonances that are retained in the
spectrum. We were able to assign three resonances in the spec-
trum of the unphosphorylated protein to Pro-2222, Pro-2369,
and Pro-2389 (Fig. 6B); all of these are remote from the poly-
proline motif (Fig. 6A).
Upon phosphorylation by PKA, resonances for many more
prolines were observed (Fig. 6C). With the assistance of amino
FIGURE 3. NS5A in cells replicating HCV RNA is phosphorylated on Thr-2332. A, loss of Thr(P)-2332 does not alter replication as measured by colony
formation. T2332A and T2232E variants were engineered into the HCV genotype 1b (Con1) subgenomic replicon in the absence (top panels) or presence
(bottom panels) of the S2204I adaptive mutation, referred to throughout as the SI replicon. Replicon replication confers resistance to G418, thus permitting
replication efficiency to be quantified by determining G418-resistant colonies per microgram of transfected replicon RNA as described (60); these values are
shown below each panel. B, loss of Thr(P)-2332 does not have a global effect on NS5A phosphorylation. Wild type replicons produce two forms of NS5A. The
p58/p56 ratios were unchanged. Errors represent S.E. n  3. C, Thr(P)-2332-NS5A is present in cells replicating HCV RNA. Extracts made from populations of cells
replicating HCV RNA encoding wild type or mutant NS5A were analyzed by Western blotting for the presence of Thr(P)-2332-NS5A using the Thr(P)-2332-
specific antibody (top) or NS5A antibody (bottom) characterized in Fig. 2D. The band indicated by the asterisk is a cellular protein that reacts with the
Thr(P)-2332-specific antibody. Recombinant NS5A and Thr(P)-2332-NS5A were used as controls. D, Thr(P)-2332 represents 20% of the total NS5A in cells
replicating HCV RNA. Standard curves were prepared using NS5A or PKA-phosphorylated NS5A in order to quantify Western blots as shown in C to determine
the number of molecules of NS5A and Thr(P)-2332-NS5A per cell. E, Thr(P)-2332-NS5A colocalizes with NS5A in cells replicating HCV RNA. Huh-7.5 cells without
HCV RNA (mock) or expressing the indicated replicon were evaluated by immunofluorescence using antibodies against NS5A and Thr(P)-2332-NS5A. Nuclear
staining observed with the antibody to Thr(P)-2332-NS5A is probably the cellular protein observed by Western blotting in C. HCV replicates in the cytoplasm,
thus limiting interference.
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acid-specific 15N,13C CON spectra (25), we were able to assign
three of these new resonances to Pro-2315, Pro-2322, and Pro-
2325, suitable probes for both PPII motifs (Fig. 6A). It appears
that the average conformations yielding the resonances
observed in the Thr(P)-2332 spectrum are not created in
response to phosphorylation, because we see them in the
unphosphorylated IDD spectrum if the concentration is suffi-
ciently high (Fig. 7). Therefore, it is likely that the ability of
phosphorylation to bring resonances of the PPII motif into view
originates from a reduction in the conformational sampling of
this region of the IDD. Interestingly, an IDD with the T2332E
substitution was indistinguishable from the IDD phosphory-
lated on Thr-2332 (Fig. 6D), suggesting that T2332E-NS5A
phenocopies the conformation of Thr(P)-2332-NS5A.
It is clear that NS5A interacts with several SH3-containing
proteins (38). Recently, it has been shown that the NS5A PPII
motif is essential for replication of genotype 2a (41). To deter-
mine the impact of an SH3 domain on the PPII motifs of NS5A,
we expressed and purified the SH3 domain from c-Src. We
chose this SH3 domain because there is evidence that the
NS5A-c-Src interaction is important for replication (42). Eval-
uation of Thr(P)-2332NS5A IDDSH3 complexes produced at
different molar ratios of the SH3 domain showed that the res-
onances induced by phosphorylation disappear in the presence
of the SH3 domain (red resonances are not present for any of
the prolines labeled green in Fig. 6E). In contrast, none of the
resonances remote from the PPII motifs are impacted by the
presence of the SH3 domain (red resonances are present for all
FIGURE 4. Phosphorylation of NS5A Thr-2332 influences steady state levels of RNA for HCV genotype 1b but is essential for replication and infectious
virus production for HCV genotype 2a. A and B, cells expressing the indicated genotype 1b replicons were used to measure the steady-state level of RNA by
RT-qPCR in A or Northern blotting in B. C, reduced RNA levels lead to reduced protein levels. Extracts were prepared from the same cells used in the previous
panels and evaluated by Western blotting using antibodies against NS5A, NS3, and NS5B. D, RNA levels change as a function of passage. We noted variability
in the magnitude of the differences observed between wild type and mutants. This variability was traced to very reproducible changes in RNA levels as a
function of passage. Total RNA was extracted from G418-resistant colonies at each split, and HCV RNA copy number was determined by RT-qPCR. Errors
represent S.E. n  3. E, requirement of Thr(P)-2332-NS5A evaluated using the HCV genotype 2a infection system, pJC1/GLuc2A (19). This viral genome encodes
the secreted Gaussia luciferase, permitting RNA synthesis to be monitored indirectly by luciferase activity. GNN, a viral genome expressing an inactive
polymerase. Huh-7.5 cells were transfected as indicated, and media were collected at 6, 24, 48, and 72 h post-transfection. Values on the y axis represent the
amount of secreted GLuc activity (shown as relative light units (RLU)) for each transfection. Errors represent S.D. n  3. F, in this experiment, medium harvested
from each time point shown in D was used as an inoculum to infect Huh-7.5 cells. Seventy-two hours later, RLU was measured. Error bars, S.D. n  3.
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of the prolines labeled black in Fig. 6E). Performing this exper-
iment with T2332E-NS5A IDD yielded the same result as
observed for Thr(P)-2332-NS5A IDD (Fig. 8A) without any per-
turbations in the spectrum for the unphosphorylated protein
(Fig. 8B). We conclude that both PPII motifs contribute to
interactions with SH3 domains and that PKA phosphorylation
near these motifs stabilizes a conformation competent for bind-
ing to SH3 domains.
Because of the unique location of phosphothreonines in
spectra produced by performing 1H,15N HSQC experiments,
we were able to identify and assign the resonance for Thr(P)-
2332 (Fig. 6F). In the presence of the SH3 domain, there was a
chemical shift perturbation followed by loss of the resonance.
This observation suggests a possible interaction of Thr(P)-2332
with the SH3 domain as well. Given the substantial structural
overlap that exists between SH3 domains, we were able to con-
struct a model of the c-Src SH3 domain bound to the PPII.2
motif based on a structure of this motif bound to the Fyn SH3
domain (Fig. 6G) (43). This model places both Pro-2322 and
Pro-2325 on c-Src SH3 domain and would suggest that Thr(P)-
2332 should be close enough to interact with the SH3 domain as
well.
Thr(P)-2332-NS5A Contributes to the Form and Function of
the HCV Replication Organelle—At this point, we assumed that
loss of Thr(P)-2332 negatively impacted interaction with one or
more cellular SH3 domains. In order to further investigate the
basis for the phenotype observed in cells producing T2332A- or
T2332E-NS5A, we decided to evaluate the colocalization of
NS5A with NS4B, a well accepted marker of the HCV membra-
nous web/replication organelle (44). By using immunofluores-
cence alone, it was obvious that the amount of NS5A-NS4B
colocalization was reduced when Thr-2332 was changed to ala-
nine (Fig. 9A). Mutation of position 2332 to glutamic acid
yielded an intermediate phenotype (Fig. 9A). In order to per-
form this experiment more quantitatively, we used confocal
microscopy to obtain the Pearson’s coefficient for NS5A-NS4B
FIGURE 5. Thr-2332 phosphorylation does not affect HCV non-structural protein or RNA decay rates. A and B, T2332A and T2332E substitutions do not
affect the decay of HCV non-structural proteins. A, Western blots of HCV non-structural proteins NS5A, NS3, and NS5B from SI, SI/T2332A, and SI/T2332E
replicon-containing cells under 100 g/ml CHX treatment. -Actin was detected as a loading control. B, plot of NS5A levels under CHX treatment at varying
time points (tn) relative to 0 h (t0) showed an equal decay of the viral protein across SI, SI/T2332A, and SI/T2332E replicon-containing cell lines. C and D, T2332A
and T2332E substitutions do not affect the decay of HCV RNA. C, top, subgenomic replicon RNA extracted from SI, SI/T2332A, and SI/T2332E replicon-containing
Huh-7.5 cells detected by Northern blot showed an increase in replicon levels over time. Bottom, Northern blot of subgenomic replicon RNA extracted from the
same replicon-containing Huh-7.5 cells treated with 100 g/ml CHX. Over 24 h, replicon levels decreased in the presence of CHX treatment. Varying amounts
of in vitro transcribed subgenomic replicon RNA were loaded as positive controls in the first four lanes of the top and bottom blots. D, plot of replicon levels under
CHX treatment at varying time points (tn) relative to 0 h (t0) showed an equal decay of SI, SI/T2332A, and SI/T2332E replicon levels over time.
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colocalization in single cells (45). In each case, 60 cells were
evaluated, and a significant difference was observed in both the
range and average colocalization observed when cells pro-
ducing T2332A- or T2332E-NS5A were compared with
those producing Thr(P)/Thr-2332-NS5A (Fig. 9B). We also
analyzed the membranous web by using transmission elec-
tron microscopy (Fig. 9C). Clustered, tubular-vesicular
structures were very apparent in cells producing Thr(P)-
2332/Thr-2332-NS5A (SI in Fig. 9C). In the absence of
Thr(P)-2332, only vesicular structures were observed; these
were not clustered (SI/T2332A in Fig. 9C). T2332E-NS5A
led to the production of demonstrably larger vesicular struc-
tures with very few tubular structures (SI/T2332E in Fig. 9C).
Some vesicles were clustered; others were not (SI/T2332E in
Fig. 9C). Collectively, these data suggest that the Thr(P)-
2332/Thr-2332-NS5A ratio is an important determinant of
the assembly and/or stability of the replication organelle.
The outcome associated with changing this ratio or this res-
idue varies depending on the HCV genotype.
PKA Activity Is Required for HCV Replication beyond Phos-
phorylation of NS5A on Thr-2332—In order to obtain evidence
for PKA as the kinase responsible for phosphorylation of Thr-
2332 in vivo, we treated cells with the PKA inhibitor, KT-5720
(46), which caused a substantial reduction in the level of
Thr(P)-2332-NS5A relative to untreated cells (compare lane 3
with lane 2 of panel pT2332-NS5A in Fig. 10A). In addition to
FIGURE 6. Phosphorylation of Thr-2332 shifts proline residues of the NS5A polyproline motif that contribute to interaction with the SH3 domain
of c-Src. A, schematic of NS5A IDD studied by NMR. Proline residues (black, boldface type) were observed in the unphosphorylated IDD. Residues of the
two type-II polyproline motifs, PPII.1 and PPII.2, are indicated. Proline residues (green) were observed only in the Thr(P)-2332- and T2332E IDDs. The
location of Thr(P)-2332 is indicated. B, prolines in NS5A IDD can be detected by NMR. Shown is the 15N,13C CON spectrum of unphosphorylated NS5A IDD
(proline region). Resonances observed represent a very small subset of the proline residues in the IDD. Three were assigned as indicated; none were in
PPII. C, phosphorylation of IDD increases the number of proline resonances detected. Shown is the 15N,13C CON spectrum with PKA-phosphorylated IDD
(NS5A IDD pT2332; green). The spectrum was overlaid with that of the unphosphorylated IDD (NS5A IDD; black). Many new resonances were observed.
Three could be assigned, and these mapped to PPII. D, NS5A IDD T2332E mimics Thr(P)-2332. The spectrum for NS5A IDD T2332E (purple) superimposes
with that of NS5A IDD Thr(P)-2332 (green). E, titration of the SH3 domain into NS5A IDD Thr(P)-2332 leads to loss of resonances induced by Thr-2332
phosphorylation. Shown are 15N,13C CON spectra of NS5A IDD Thr(P)-2332 with 0 –2 eq of unlabeled c-Src SH3. The absence of red resonances at
positions where green resonances are visible indicates a dynamical response to the presence of c-Src. F, chemical shift perturbation of Thr(P)-2332 in
response to the presence of c-Src. 1H,15N HSQC spectra are zoomed in on the Thr(P) region for NS5A IDD Thr(P)-2332 with 0 –2 eq of unlabeled c-Src SH3.
This resonance is also sensitive to the presence of c-Src. G, molecular model of c-Src SH3 domain in complex with NS5A PPII peptide, APPIPPPR. The
model was derived from a structure of FYN-SH3 domain in complex with NS5A PPII peptide (43) and structure of c-Src SH3 domain (61). Proline residues
whose resonances appear in the presence of phosphorylation and disappear in the presence of c-Src are clearly capable of binding to the protein. The
Thr(P)-2332 would be predicted to be close enough to the protein surface for interaction.
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KT-5720, three other inhibitors of PKA have been used widely
in the literature: H-7 (47), H-89 (48), and 14 –22 (49). All of
these inhibitors prevent NS5A phosphorylation by PKA in vitro
(Fig. 11A) and in cells replicating HCV RNA (Fig. 11B).
Because loss of NS5A phosphorylation on Thr-2332 caused
perturbations in the integrity of the replication organelle, as
determined by NS5A-NS4B colocalization (Fig. 9), we evalu-
ated the impact of KT-5720 on integrity of the replication
organelle (Fig. 10B). As expected, treatment of SI cells with
KT-5720 caused disruption of the replication organelle (panel
KT-5720 in Fig. 10B). In order to determine whether loss of
Thr(P)-2332-NS5A was reversible and would lead to reestab-
lishment of the replication organelle (i.e. NS5A-NS4B colocal-
ization), we removed the PKA inhibitor but added CHX to
ensure that any Thr(P)-2332-NS5A observed would derive
from existing pools of NS5A instead of newly translated NS5A.
Under these conditions, Thr(P)-2332-NS5A was again pro-
duced (lanes 4 and 5 of panel pT2332 in Fig. 10A). Interestingly,
reestablishment of the replication organelle was not observed
based on NS5A-NS4B colocalization (panels CHX in Fig.
10B). This suggests that once phosphorylation ceases and the
replication organelle is disrupted, polyprotein synthesis may be
required for reestablishment of the replication organelle.
If phosphorylation of NS5A on Thr-2332 is the only function
of PKA for replication of HCV RNA, then treatment of SI cells
with a PKA inhibitor should phenocopy the SI/T2332A mutant.
When SI cells were treated for 24 h with 2 M (10  IC50)
KT-5720, the steady-state level of HCV replicon RNA was
reduced by an order of magnitude (Fig. 10C). Interestingly, the
steady-state level of HCV replicon RNA was also reduced in
SI/T2332A and SI/T2332E cells (Fig. 10C), suggesting that tar-
gets of PKA phosphorylation other than NS5A contribute to
HCV RNA replication. Consistent with the reduction in the
steady-state level of RNA in SI/T2332A and SI/T2332E cells
caused by the PKA inhibitor (Fig. 10C), KT-5720 treatment led
to even further disruption of the replication organelles in these
cells (panels SI/T2332A and SI/T2332E in Fig. 10D). These data
suggest that other viral and/or cellular substrates of PKA are
required for assembly, stability, and/or function of the replica-
tion organelle. All four inhibitors of PKA caused disruption of
FIGURE 7. PKA phosphorylation alters the observed resonances for NS5A IDD. Shown is a comparison of NMR spectra for unphosphorylated and PKA-
phosphorylated NS5A IDD. In the left panel is the 15N,13C CON spectra of NS5A IDD (black) overlaid with the 15N,13C CON spectra of NS5A IDD Thr(P)-2332 (green)
zoomed to the proline region of the spectrum. The proline residue resonances that appear upon phosphorylation are indicated with green letters. In the right
panel is the 15N,13C CON spectra of NS5A IDD (black) overlaid with 15N,13C CON spectra of NS5A IDD at high concentration (red). Only at very high concentrations
of unphosphorylated NS5A IDD do resonances begin to appear that are similar to resonances observed for PKA-phosphorylated NS5A IDD (resonances labeled
with the same letter code as in the left panel but in red).
FIGURE 8. Binding of SH3 domain favors interaction with PKA-phosphorylated NS5A IDD. A, the 15N,13C CON spectra of NS5A IDD T2332E with 0 (purple),
1 (pink), and 2 (red) eq of unlabeled SH3 added zoomed to the proline region of the spectrum. B, the 15N,13C CON spectra of unphosphorylated NS5A IDD with
0 (black), 0.5 (cyan), 1 (pink), and 2 (red) eq of unlabeled SH3 domain added zoomed to the proline region of the spectrum.
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the replication organelle, although the fate of the NS5A and
NS4B proteins differed for each inhibitor (Fig. 11C). We con-
clude that PKA activity is essential for HCV genome
replication.
Relocalization of PKA in Cells Replicating HCV RNA—Hav-
ing established that PKA does indeed phosphorylate NS5A on
Thr-2332, we asked whether this phosphorylation occurred by
recruiting PKA into the replication organelle. In naive Huh-7.5
cells, PKAc showed a preferential localization to the Golgi
(PKAc in panel mock in Fig. 12A). In this experiment, the Golgi
was stained with an antibody to the protein giantin (giantin in
panel mock in Fig. 12A). In cells replicating HCV RNA, the
Golgi-localized fraction of PKA was lost (PKAc in panel SI in
Fig. 12A). Importantly, the Golgi remained intact in cells repli-
cating HCV RNA. (giantin in panel SI in Figs. 12A and 13). The
loss of Golgi-associated PKA in cells replicating HCV RNA did
not require the ability of NS5A to be phosphorylated on Thr-
2332 because the T2332A and T2332E mutants showed this
phenotype (Fig. 12B). Although PKA did not accumulate in the
replication organelle, the catalytic subunit was clearly present
in the replication organelle, based on its colocalization with
NS5A (Fig. 12B). Disruption of the replication organelle by pre-
cluding Thr-2332 phosphorylation was also sufficient to dis-
rupt colocalization of PKA with NS5A (Fig. 12B). The ability of
PKA and NS5A to colocalize in cells may facilitate NS5A phos-
phorylation on Thr-2332. However, it is also possible that the
relocalization of PKA from the Golgi to the cytoplasm may be
sufficient for NS5A phosphorylation prior to its association
with the replication organelle.
DISCUSSION
HCV NS5A contributes to genome replication, virion assem-
bly, and myriad interactions with the host cell (7). How this
protein interfaces with so many different viral and cellular
pathways is unknown. It is well established that NS5A is a phos-
phoprotein (27). These early studies showed that NS5A
migrated as 56- and 58-kDa species in SDS-polyacrylamide
gels. The fact that the calculated molecular mass of NS5A is 49
kDa led to the conclusion that all NS5A produced in cells is
phosphorylated, with basal (56-kDa) and hyperphosphorylated
(58-kDa) forms (27). Later, it became clear that even unphos-
phorylated NS5A has a gel mobility of 56 kDa (18). The aberrant
gel mobility is probably a reflection of the intrinsic disorder
FIGURE 9. Phosphorylation of Thr-2332 contributes to the integrity of the HCV membranous web/replication organelle. A, reduced colocalization of
NS5A and NS4B in the absence of Thr(P)-2332-NS5A. Immunofluorescence was used to evaluate the replication organelle. NS4B is used as a marker for the
replication organelle, with good colocalization implying integrity of this organelle (44). Cells replicating the indicated HCV 1b replicon were stained for NS5A
(green) and NS4B (red), so yellow indicates colocalization. When there is a fourth panel in a row, it shows the region in the merge panel that is in the white box.
B, quantitative analysis of NS5A-NS4B colocalization. Visual analysis of images like those shown in A revealed extensive heterogeneity in the extent of
NS5A-NS4B colocalization in cells replicating the SI replicon. To remove bias, we used a confocal microscope and determined colocalization (Pearson’s
coefficient) in entire cells. Three trials were performed; each trial used 20 cells per construct. p values were calculated using a two-tailed paired t test. C, loss of
integrity of replication organelle also observed by transmission electron microscopy. In order to demonstrate that the changes in NS5A-NS4B colocalization
corresponded to changes in the replication organelle ultrastructure, portions of the cells used in A were processed for transmission electron microscopy. Bar,
1 m.
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and/or proline-rich nature of the carboxyl-terminal two-thirds
of NS5A (5, 6).
Phosphorylation and other post-translational modifications
of an IDD of a protein can induce and/or stabilize structure,
which, in turn, can confer unique function (8). Therefore, we
hypothesized that single and multiple phosphorylation events
of NS5A create forms of the viral protein with unique functions,
thus explaining the promiscuous binding of NS5A. In order to
test this possibility, a clear link between a phosphorylation
site(s) on NS5A and a specific kinase is necessary. When a min-
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imum cut-off of 1 eq of phosphate/eq of protein is required for
that protein to be considered a substrate of a kinase, PKA is only
capable of phosphorylating NS5A, although NetPhosK predicts
numerous sites in NS3 and NS5B (Fig. 1). Mass spectrometry,
reverse genetics, and a phospho-specific antibody showed that
Thr-2332 (polyprotein numbering; residue 360 of processed
NS5A) was the site of phosphorylation in vitro (Fig. 2). The
latter two approaches permitted confirmation of this phosphor-
ylation site in cells (Fig. 3).
Thr-2332 is located adjacent to two PPII motifs in NS5A (Fig.
6A). Our biophysical analysis (Fig. 6) is consistent with these
motifs sampling multiple conformations on the millisecond
time scale and Thr(P)-2332 restricting the sampling to confor-
mations that are competent for binding to SH3 domains. It is
FIGURE 10. PKA targets other than NS5A are required for HCV replication. A, PKA phosphorylates NS5A at Thr-2332 in cells replicating HCV RNA. In order
to demonstrate that PKA was indeed phosphorylating NS5A on Thr-2332 in cells, cells were treated with DMSO (lane 2) or the PKA inhibitor, KT-5720 (lane 3),
for 24 h. The effect of treatment on Thr(P)-2332-NS5A and NS5A was determined by Western blotting. Huh-7.5 cells were used as a negative control (mock, lane
1); detection of calnexin served as a loading control. In order to determine whether dephosphorylated NS5A could be rephosphorylated, cycloheximide, a
translation inhibitor, was added upon removal of the PKA inhibitor, KT-5720, and probed 12 (lane 4) or 24 h (lane 5) thereafter. Similar observations were made
using other PKA inhibitors (Fig. 11). B, PKA inhibitors cause an irreversible loss in integrity of the replication organelle. The impact of the treatments performed
in A on the replication organelle was determined by using immunofluorescence to evaluate NS5A-NS4B colocalization as described above. C, inhibition of PKA
has a greater impact on HCV RNA levels than loss of pT2332. RT-qPCR was used to determine the copy number of HCV RNA in cells treated with DMSO or
KT-5720. Errors represent S.E. n  3. D, inhibition of PKA further exacerbates loss of integrity of the replication organelle caused by substitutions at Thr-2332.
Immunofluorescence was used to evaluate the integrity of the replication organelle for the wild-type replicon or the indicated Thr-2332 variant in the absence
(DMSO) or presence (KT-5720) of the PKA inhibitor. The white box in the merge panel is enlarged in the bottom right of each quadrant. This experiment was
repeated with other PKA inhibitors (Fig. 11).
FIGURE 11. Commercially available PKA inhibitors (PKAi) disrupt HCV replication organelles. A, the IC50 values of four commercially available PKA
inhibitors were calculated using standard phosphorylation reaction conditions with 50 M ATP, 0.5 M NS5A, 0.005 M PKA, and 2.5% DMSO. Final concen-
trations of the inhibitors varied from 0 to 50 M. The IC50 values were determined by plotting the data and fitting to a hyperbolic equation. S.E. values are from
non-linear regression fits of the data. B, PKA inhibitors decrease Thr(P)-2332-NS5A, as shown by Western blot. Top, a decrease in Thr(P)-2332-NS5A was
observed in SI replicon-containing cells treated for 24 h with 10 IC50 of PKA inhibitors H-7, H-89, KT-5720, and 14-22 relative to cells treated for the same time
with 0.5% DMSO. The same blot was also probed with anti-NS5A (middle) and anti-calnexin (bottom). C, immunofluorescence of SI replicon-containing Huh-7.5
cells in the presence of 0.5% DMSO or 10 IC50 PKA inhibitor H-7, H-89, KT-5720, or 14-22 for 24 h. Colocalization between NS5A (green) and NS4B (red) was
nearly ubiquitous in DMSO-treated cells. Cells treated with H-7 showed a slight change in colocalization between the viral proteins; however, cells treated with
H-89, KT-5720, and 14-22 had more dispersed HCV replication organelles.
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also possible that the phosphorylation-dependent changes
were caused by acceleration of the conformational dynamics
into the picosecond to microsecond time scale. Phosphoryla-
tion-dependent changes in aggregation state were ruled out
using dynamic light scattering (data not shown).
The ability of phosphorylation to regulate IDD conformation
provides an explanation for cellular PPII motifs being located
near phosphorylation sites (40). Phosphorylation need not
always reduce conformational sampling; the context of the PPII
motif would probably contribute to conformation. The rela-
tionship between conformational sampling and binding affinity
remains to be determined. In addition, it is easy to imagine that
other post-translational modifications affect function in a sim-
ilar manner by modulating conformational sampling to pro-
mote or to interfere with a biomolecular interaction. Others
have seen and/or proposed post-translational modification-de-
pendent changes in motifs found in IDPs (50, 51). The novelty
of this study is that we observe the prolines directly and provide
an unambiguous link between a remote phosphorylation event
and the conformation and dynamics of specific prolines. There-
fore, these studies define the 15N,13C CON NMR strategy as a
powerful approach for studying viral and cellular PPII motifs
and interactions thereof.
The experimental paradigm used here to discover Thr(P)-
2332 will be useful for identifying additional, specific sites of
NS5A phosphorylation and the corresponding kinases. Two-
dimensional gel analysis of NS5A present in Huh-7 cells persis-
tently replicating HCV suggests many different phosphorylated
species of the 56-kDa form, with pI values ranging from 4.0 to
5.5 (3). However, attempts to identify NS5A phosphorylation
sites have yielded only a few sites (28 –32). None of these studies
identified Thr-2332. The Thr(P)-2332-NS5A species repre-
sents only 20% of total NS5A in cells (Fig. 3D). Therefore, this
experimental paradigm clearly uncovers sites that have eluded
direct approaches using NS5A isolated from HCV-replicating
cells.
We conclude that Thr(P)-2332-NS5A, other PKA targets,
and even other phosphorylated forms of NS5A contribute to
form and function of the replication organelle. The NS5A IDD
is among the most variable protein in the HCV proteome. It is
possible that the NS5A phosphoproteome is equally variable.
This variability may lead to differences in host factors used by
FIGURE 12. HCV replication leads to changes in localization of PKAc. A, PKAc enrichment at the Golgi apparatus in Huh-7.5 cells. The localization of PKAc
(red) was determined by immunofluorescence. PKAc was present throughout the cell but did seem to be concentrated in a portion of the cytoplasm. Staining
for giantin (green), a marker of the Golgi apparatus, was consistent with enrichment of PKAc at the Golgi apparatus. The nucleus was stained with DAPI (purple).
The bottom right quadrant is a merge of the three other panels. B, Golgi fragmentation and loss of PKAc localization in Huh-7.5 cells replicating HCV RNA. The
localization of PKAc (red) was determined in SI cells as described in A. The staining was much more diffuse than observed in A. Giantin (green) staining was
fragmented in these cells. Whether the former phenotype is caused by the latter or vice versa or whether they are unrelated could not be determined
unambiguously. C, PKAc does not localize to the replication organelle. In order to determine whether PKAc was present in the replication organelle, wild-type
and Thr-2332 mutant replicons were stained for NS5A (green) and PKAc (red). The last panel in each row is the region within the white box of the merge panel.
Giantin staining was also performed (Fig. 13).
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different genotypes and the ability to antagonize host defenses
required to establish persistence. Clearly, the NS5A phospho-
proteome encoded by Con1b/S2204I and Jc1–2a genotypes of
HCV used in this study is different, because Jc1–2a produces
the p58 form of NS5A, and Con1b/S2204I does not. The mag-
nitude of the response of these genotypes to loss of Thr(P)-2332
is substantially different (Fig. 4).
Dozens of host factors have been implicated in HCV genome
replication and many (re)localize to the replication organelle
(52). Of these, several are thought to be recruited by interacting
with NS5A. Interestingly, two NS5A-interacting and replica-
tion organelle-associated host factors are regulated by PKA;
these are annexin A2 (53, 54) and Raf-1 kinase (55). Annexin A2
interacts with phosphoinositides to form membrane microdo-
mains of distinct protein composition, and these microdomains
exhibit altered membrane dynamics (56). Phosphorylation of
annexin A2 by PKA has been shown to promote its association
with membranes. Raf-1 kinase interacts with Ras, and this
interaction is disrupted by PKA phosphorylation of Raf-1 (57).
Disruption of the Raf-1-Ras interaction may permit Raf-1 to
localize to the replication organelle, thereby contributing to
formation and/or stabilization of the replication organelle.
Therefore, annexin A2 and Raf-1 are candidate host factors that
may contribute to regulation of replication organelle structure
by PKA.
It is possible that the ability to regulate assembly and disas-
sembly of the replication organelle contributes to the ability of
HCV to persist. This possibility is suggested by the observation
that the difference in the steady-state level of RNA observed for
the Thr-2332 mutants relative to wild type only manifests after
multiple cell divisions (Fig. 4C). When the replication organelle
is assembled, HCV replicase components are perinuclear and in
an asymmetric organization (Fig. 3E). Therefore, it is possible
that in this state partitioning between daughter cells may be
asymmetric. When disassembled, components of the replica-
tion organelle are more homogeneous (Fig. 10D) and may be
more equally distributed between daughter cells. Consistent
with this possibility is the fact that cAMP concentration and
PKA activity are highest at G1 and lowest at mitosis (58).
The NS5A phosphoproteome may be a highly efficacious tar-
get for development of anti-HCV agents. This idea is inspired
by the recent discovery of daclatasvir, a drug thought to inhibit
HCV genome replication by binding to NS5A, preventing
hyperphosphorylation (14, 15) and disrupting the replication
organelle (59). Evidence for direct binding of daclatasvir and
related compounds to NS5A has been difficult to obtain (59).
That NS5A is the target is supported primarily by drug resis-
tance mutations (15). The effective concentration of daclatasvir is
in the picomolar range; however, the concentration of NS5A in
cells replicating HCV RNA is on the order of micromolar (14).
Is it possible that the target is one of the many phosphor-
ylated forms of NS5A? If this were the case, the picomolar effi-
cacy could be related to binding of the drug to a NS5A species
that is present at sub-picomolar levels. Analysis of the NS5A
phosphoproteome after daclatasvir treatment may permit this
possibility to be tested.
This study makes a very compelling case for the use of phos-
phorylation in the intrinsically disordered domain of NS5A to
expand the functional proteome of HCV. Interestingly, evalua-
tion of phosphorylated proteins of other RNA viruses reveals
that these proteins have intrinsically disordered domains, and
known phosphorylation sites map to these domains (Table 3).
We speculate that phosphorylation in IDDs of viral proteins
may be a general mechanism employed by RNA viruses to
expand their functional proteomes.
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